Shares of HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-four brokerages that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and sixteen have assigned a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $480.13.
HCA has been the topic of several research reports. Oppenheimer lowered their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research report on Monday, July 27th. Bank of America upped their target price on HCA Healthcare from $450.00 to $500.00 and gave the company a “neutral” rating in a research note on Wednesday, October 28th. Morgan Stanley dropped their price target on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research report on Monday, July 27th. Leerink Partners reissued an “outperform” rating and issued a $492.00 price target on shares of HCA Healthcare in a report on Friday, September 18th. Finally, KeyCorp increased their price objective on HCA Healthcare from $435.00 to $490.00 and gave the company an “overweight” rating in a research note on Wednesday, October 28th.
Get Our Latest Stock Report on HCA Healthcare
Key HCA Healthcare News
Investors following HCA have been watching these news items:
- Neutral Sentiment: Zacks Research’s estimate changes were mixed: its FY2026 EPS forecast rose to $30.00, but it cut FY2027 to $30.87 and FY2028 to $33.98. The revisions offer a less uniformly strong forward earnings signal. HCA Healthcare analyst estimate updates
- Negative Sentiment: Medicaid policy is a risk to earnings: HCA expects $550 million to $650 million less in Medicaid supplemental payment benefits in 2027, potentially adding reimbursement pressure. Value stocks offer a different path forward
- Negative Sentiment: A senior vice president reportedly sold about $1.77 million in HCA shares. Insider sales can weigh on sentiment, although a sale alone does not establish a negative outlook. Insider selling at HCA Healthcare
Insider Transactions at HCA Healthcare
In related news, COO Jon M. Foster sold 21,713 shares of the firm’s stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the sale, the chief operating officer owned 10,000 shares in the company, valued at approximately $4,949,500. This trade represents a 68.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Erica Rossitto sold 3,500 shares of the business’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $505.81, for a total value of $1,770,335.00. Following the completion of the transaction, the senior vice president owned 13,426 shares of the company’s stock, valued at $6,791,005.06. This trade represents a 20.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 36,413 shares of company stock worth $18,251,464 over the last ninety days. 1.50% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On HCA Healthcare
Several large investors have recently added to or reduced their stakes in the business. DiPaolo Financial Group Inc. acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth $29,000. MidFirst Bank acquired a new position in HCA Healthcare in the second quarter valued at $28,000. Clearstead Trust LLC purchased a new stake in HCA Healthcare during the second quarter valued at about $29,000. Latitude Advisors LLC acquired a new stake in HCA Healthcare during the third quarter worth about $32,000. Finally, Delos Wealth Advisors LLC acquired a new stake in HCA Healthcare during the second quarter worth about $35,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare Price Performance
NYSE HCA opened at $498.82 on Wednesday. The business has a 50 day moving average price of $452.79 and a 200 day moving average price of $445.91. The company has a market capitalization of $104.20 billion, a P/E ratio of 16.53, a PEG ratio of 1.67 and a beta of 1.11. HCA Healthcare has a 1-year low of $353.99 and a 1-year high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. The company had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. HCA Healthcare’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the previous year, the business earned $6.96 earnings per share. On average, research analysts expect that HCA Healthcare will post 30.14 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio is 10.34%.
HCA Healthcare Company Profile
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Read More
- Five stocks we like better than HCA Healthcare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
